Ismael, Musa M.
HRN: 24-46-58 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/26/2024
02/02/2024
IVTT
1.5 Gram
Q6H
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes